Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in

  News Archive

Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Tuesday, July 14, 2015
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.

Researchers Link Liver Disease and Drug Metabolism
Monday, July 13, 2015
Researchers have discovered that nonalcoholic steatohepatitis, an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.

Darin Leigh Joins Metabolon as Chief Commercial Officer
Tuesday, July 07, 2015
New role to lead commercial strategy for biomarker discovery, precision medicine, and diagnostics products and services.

Scientists Create Synthetic Membranes That Grow Like Living Cells
Wednesday, July 01, 2015
Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.

Potential New Class of Cancer Drugs
Tuesday, June 30, 2015
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.

EU Recommends Approval for Alexion's Rare Disease Drugs
Tuesday, June 30, 2015
Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

ELRIG Announces Drug Discovery 2015 Programme
Thursday, June 25, 2015
The company announced today the details of the programme for the 9th annual Drug Discovery 2015 conference and exhibition.

Team Led by TSRI Scientists Shows AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
Thursday, June 25, 2015
New research shows that an experimental vaccine candidate can stimulate immune activity necessary to prevent HIV infection.

SOLVO Biotechnology and Hepregen Execute Co-Marketing Agreement
Wednesday, June 24, 2015
Agreement provides for European sales of Hepregen's HepatoPac® and HepatoMune™ proprietary products by SOLVO and provision of services using these products.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1522
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos